188 related articles for article (PubMed ID: 35758158)
1. N(6)-methyladenosine-mediated miR-380-3p maturation and upregulation promotes cancer aggressiveness in pancreatic cancer.
Jiang Z; Song X; Wei Y; Li Y; Kong D; Sun J
Bioengineered; 2022 Jun; 13(6):14460-14471. PubMed ID: 35758158
[TBL] [Abstract][Full Text] [Related]
2. Methyltransferase-like 3 (METTL3) mediated N6-methyladenosine (m6A) modifications facilitate mir-25-3p maturation to promote gastrointestinal stromal tumors (GISTs) progression.
Qian K; Xu W; Xia X; Ding J
Genes Genomics; 2022 Dec; 44(12):1519-1530. PubMed ID: 36040683
[TBL] [Abstract][Full Text] [Related]
3. METTL3 m6A-dependently promotes miR-21-5p maturation to accelerate choriocarcinoma progression via the HIF1AN-induced inactivation of the HIF1A/VEGF pathway.
Ye K; Li L; Wu B; Wang D
Genes Genomics; 2022 Nov; 44(11):1311-1322. PubMed ID: 36074324
[TBL] [Abstract][Full Text] [Related]
4. N6-methyladenosine-mediated upregulation of LINC00520 accelerates breast cancer progression via regulating miR-577/POSTN axis and downstream ILK/AKT/mTOR signaling pathway.
Guo Y; Feng L
Arch Biochem Biophys; 2022 Oct; 729():109381. PubMed ID: 36027936
[TBL] [Abstract][Full Text] [Related]
5. METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway.
Bi X; Lv X; Liu D; Guo H; Yao G; Wang L; Liang X; Yang Y
Cancer Gene Ther; 2021 Apr; 28(3-4):335-349. PubMed ID: 32939058
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of METTL3 attenuates high-glucose induced RPE cell pyroptosis by regulating miR-25-3p/PTEN/Akt signaling cascade through DGCR8.
Zha X; Xi X; Fan X; Ma M; Zhang Y; Yang Y
Aging (Albany NY); 2020 May; 12(9):8137-8150. PubMed ID: 32365051
[TBL] [Abstract][Full Text] [Related]
7. FTO-stabilized miR-139-5p targets ZNF217 to suppress prostate cancer cell malignancies by inactivating the PI3K/Akt/mTOR signal pathway.
Azhati B; Reheman A; Dilixiati D; Rexiati M
Arch Biochem Biophys; 2023 Jun; 741():109604. PubMed ID: 37080415
[TBL] [Abstract][Full Text] [Related]
8. M
Chen JQ; Tao YP; Hong YG; Li HF; Huang ZP; Xu XF; Zheng H; Hu LK
Cell Cycle; 2021 Dec; 20(23):2507-2518. PubMed ID: 34658294
[TBL] [Abstract][Full Text] [Related]
9. Excessive miR-25-3p maturation via N
Zhang J; Bai R; Li M; Ye H; Wu C; Wang C; Li S; Tan L; Mai D; Li G; Pan L; Zheng Y; Su J; Ye Y; Fu Z; Zheng S; Zuo Z; Liu Z; Zhao Q; Che X; Xie D; Jia W; Zeng MS; Tan W; Chen R; Xu RH; Zheng J; Lin D
Nat Commun; 2019 Apr; 10(1):1858. PubMed ID: 31015415
[TBL] [Abstract][Full Text] [Related]
10. Hypoxic pancreatic stellate cell-derived exosomal mirnas promote proliferation and invasion of pancreatic cancer through the PTEN/AKT pathway.
Cao W; Zeng Z; He Z; Lei S
Aging (Albany NY); 2021 Feb; 13(5):7120-7132. PubMed ID: 33653966
[TBL] [Abstract][Full Text] [Related]
11. MiR-25-3p promotes malignant phenotypes of retinoblastoma by regulating PTEN/Akt pathway.
Wan W; Wan W; Long Y; Li Q; Jin X; Wan G; Zhang F; Lv Y; Zheng G; Li Z; Zhu Y
Biomed Pharmacother; 2019 Oct; 118():109111. PubMed ID: 31336343
[TBL] [Abstract][Full Text] [Related]
12. LINC00960 regulates cell proliferation and glycolysis in pancreatic cancer through the miR-326-3p/TUFT1/AKT-mTOR axis.
Zhou B; Lei JH; Wang Q; Qu TF; Cha LC; Zhan HX; Liu SL; Hu X; Sun CD; Cao JY; Qiu FB; Guo WD
Kaohsiung J Med Sci; 2022 Dec; 38(12):1155-1167. PubMed ID: 36149758
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
14. miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer.
Long M; Zhan M; Xu S; Yang R; Chen W; Zhang S; Shi Y; He Q; Mohan M; Liu Q; Wang J
Mol Cancer; 2017 Oct; 16(1):167. PubMed ID: 29078789
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of TUG1/miRNA-299-3p Axis Represses Pancreatic Cancer Malignant Progression via Suppression of the Notch1 Pathway.
Xu K; Zhang L
Dig Dis Sci; 2020 Jun; 65(6):1748-1760. PubMed ID: 31655908
[TBL] [Abstract][Full Text] [Related]
16. MiR-203a-3p Inhibits Pancreatic Cancer Cell Proliferation, EMT, and Apoptosis by Regulating SLUG.
An N; Zheng B
Technol Cancer Res Treat; 2020; 19():1533033819898729. PubMed ID: 32301392
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-23b-3p promotes pancreatic cancer cell tumorigenesis and metastasis via the JAK/PI3K and Akt/NF-κB signaling pathways.
Zhang Y; Chen D; Zhang G; Wu X; Zhou L; Lin Y; Ding J; An F; Zhan Q
Oncol Lett; 2020 Nov; 20(5):160. PubMed ID: 32934728
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-103a-3p Promotes Cell Proliferation and Invasion in Non-Small-Cell Lung Cancer Cells through Akt Pathway by Targeting PTEN.
Li H; Huhe M; Lou J
Biomed Res Int; 2021; 2021():7590976. PubMed ID: 34307670
[TBL] [Abstract][Full Text] [Related]
19. METTL3-Induced miR-222-3p Upregulation Inhibits STK4 and Promotes the Malignant Behaviors of Thyroid Carcinoma Cells.
Lin S; Zhu Y; Ji C; Yu W; Zhang C; Tan L; Long M; Luo D; Peng X
J Clin Endocrinol Metab; 2022 Jan; 107(2):474-490. PubMed ID: 34562008
[TBL] [Abstract][Full Text] [Related]
20. METTL14-mediated m
Fan HN; Chen ZY; Chen XY; Chen M; Yi YC; Zhu JS; Zhang J
Mol Cancer; 2022 Feb; 21(1):51. PubMed ID: 35164771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
